Publication | Closed Access

Open-label, multi-center, non-randomized, single-arm study to evaluate the safety and efficacy of dendritic cell immunotherapy in patients with refractory solid malignancies, on supportive care

Dendritic Cell ImmunotherapyCancer ImmunosurveillanceOncologyRefractory Solid MalignanciesImmunologyImmune Checkpoint InhibitorImmunotherapyMedicine